Market Cap (In INR)
9.87 Billion
Revenue (In INR)
16.84 Billion
Net Income (In INR)
49.95 Million
Avg. Volume
541.71 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 26.2-56.39
- PE
- -
- EPS
- -
- Beta Value
- 1.027
- ISIN
- INE023H01027
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Amit Chadah
- Employee Count
- -
- Website
- https://www.neclife.com
- Ipo Date
- 2005-07-19
- Details
- Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and mint derivatives and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
More Stocks
-
1551
-
ANIKINDSAnik Industries Limited
ANIKINDS
-
OMH
-
ELAN
-
WFG
-
SAHYADRISahyadri Industries Limited
SAHYADRI
-
ALU
-
BURNPURBurnpur Cement Limited
BURNPUR